Current role
Biotechnology · Healthcare
Board Member
2024-05-07–present
Wendell Wierenga, Ph.D.
Board Member
Dermata Therapeutics, Inc. (DRMA)Equibles does not estimate personal net worth.
Get an email with a short summary when Dermata Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get DRMA alertsAbout Wendell Wierenga, Ph.D.
Wendell Wierenga, Ph.D. is recorded as Board Member at Dermata Therapeutics, Inc. (DRMA) since May 7, 2024. Dermata Therapeutics, Inc. reported in an 8-K filed May 7, 2024 that Wendell Wierenga, Ph.D. was appointed Class III director, effective May 7, 2024. Dermata Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Dermata Therapeutics, Inc. includes Gerald T. Proehl (CEO and Board Member), Kyri K. Van Hoose (CFO), Kyri Van Hoose (CFO) and 7 others.
“The election of Gerald T. Proehl, Wendell Wierenga, Ph.D., and Kathleen Scott as Class III directors to hold office for a term of three years, until their successor is duly elected and qualified or they are otherwise unable to complete their term.”
Affiliation history
-
Current
2024-05-07–present
Company network
Leadership on record at Dermata Therapeutics, Inc.
- Gerald T. Proehl CEO, Board Member
- Kyri K. Van Hoose CFO
- Kyri Van Hoose CFO
- Andrew Sandler Board Member
- Brittany Bradrick Board Member
- David Hale Board Member
- Kathleen Scott Board Member
- Steven Mento Board Member
- Steven Mento, Ph.D. Board Member
- To approve Board Member